448 related articles for article (PubMed ID: 8452322)
41. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
[TBL] [Abstract][Full Text] [Related]
42. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
43. [Microalbuminuria in insulin-dependent diabetics: the prevention of diabetic nephropathy].
Durruty P; Krause P; Pérez F; García de los Ríos M; López G; Durruty G
Rev Med Chil; 1990 Dec; 118(12):1319-25. PubMed ID: 2152662
[TBL] [Abstract][Full Text] [Related]
44. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
45. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
Shigihara T; Sato A; Hayashi K; Saruta T
Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
Ito S; Shikata K; Nangaku M; Okuda Y; Sawanobori T
Clin J Am Soc Nephrol; 2019 Aug; 14(8):1161-1172. PubMed ID: 31248950
[TBL] [Abstract][Full Text] [Related]
47. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
Moriyama T; Oka K; Ueda H; Imai E
Clin Exp Nephrol; 2004 Sep; 8(3):230-6. PubMed ID: 15480900
[TBL] [Abstract][Full Text] [Related]
48. Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects.
Ahmad J; Shafique S; Abidi SM; Parwez I
Diabetes Res Clin Pract; 2003 May; 60(2):131-8. PubMed ID: 12706322
[TBL] [Abstract][Full Text] [Related]
49. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
[TBL] [Abstract][Full Text] [Related]
50. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
[TBL] [Abstract][Full Text] [Related]
51. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.
Ihle BU; Whitworth JA; Shahinfar S; Cnaan A; Kincaid-Smith PS; Becker GJ
Am J Kidney Dis; 1996 Apr; 27(4):489-95. PubMed ID: 8678058
[TBL] [Abstract][Full Text] [Related]
53. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
Romanelli G; Giustina A; Bossoni S; Caldonazzo A; Cimino A; Cravarezza P; Giustina G
Diabetes; 1990 Nov; 39(11):1333-8. PubMed ID: 2227107
[TBL] [Abstract][Full Text] [Related]
54. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
Agha A; Bashir K; Anwar E
Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
[TBL] [Abstract][Full Text] [Related]
55. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
[TBL] [Abstract][Full Text] [Related]
56. [Enalapril in patients with diabetes mellitus type I with microalbuminuria without hypertension].
Semetkowska-Jurkiewicz E; Milewski J; Krupa-Wojciechowska B; Wójcikowski C; Horoszek-Maziarz S
Pol Tyg Lek; 1993 Jan 4-11; 48(1-2):19-21, 26. PubMed ID: 8361875
[TBL] [Abstract][Full Text] [Related]
57. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.
Chan JC; Cockram CS; Nicholls MG; Cheung CK; Swaminathan R
BMJ; 1992 Oct; 305(6860):981-5. PubMed ID: 1458144
[TBL] [Abstract][Full Text] [Related]
58. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
59. Renal protective effect of enalapril in diabetic nephropathy.
Björck S; Mulec H; Johnsen SA; Nordén G; Aurell M
BMJ; 1992 Feb; 304(6823):339-43. PubMed ID: 1540729
[TBL] [Abstract][Full Text] [Related]
60. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.
Marre M; Leblanc H; Suarez L; Guyenne TT; Ménard J; Passa P
Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1448-52. PubMed ID: 3038254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
